孙胜波 韩传吉 张焕虎 周少杰 王文昌

    ObjectiveTo approach the contribution of chemotherapy of TACE(Transcatheter Arterial Chemoembolization)associated PVC(portal vein chemotherapy)per-DDS(Drug Delivery System)to prevent the recurrence of hepatic cell cancer(HCC)and portal vein tumor thrombus(PVTT).MethodsWe treated 97 cases with HCC and PVTT from January 2006 to January 2008，resceted the tumor and tumor thrombus of all cases，random divided them into 3 groups.Give the TACE only to group A，PVC per-DDS only to group B ，TACE and PVC per-DDS to group C.Follow-up visit and contrast the disease free survivals(DFS)and accumulative survival rates between the 3 groups at 6 months，1year and 2 years after the operation.ResultsThe contrast the DFSs and accumulative survival rates of group C all exceeds group A ’s and group B ’s at 6 months，1year and 2 years after the operation.There is difference with significance only at 2 years after the operation.Conclusion

    For the patients with HCC and PVTT ......